福晶科技(002222.SZ):子公司華晶投資競買武漢華日5%股權已完成交割
格隆匯5月13日丨福晶科技(002222.SZ)公告,公司於2020年1月11日披露了《關於子公司擬參與競買武漢華日精密激光股份有限公司5%股權的公告》,公司的全資子公司福建華晶投資有限公司(以下簡稱“華晶投資”)擬以自有資金不超過1800萬元參與競買武漢華日精密激光股份有限公司(以下簡稱“武漢華日”)5%的股權。華晶投資於2020年5月13日收到武漢光谷聯合產權交易所出具的《產權交易鑑證書》和武漢華日出具的《股東名冊》,截至本公告披露之日,本次交易已完成交割手續,實際成交價為1761.68萬元,另支付交易手續費18.16萬元。本次交易完成後,華晶投資持有武漢華日5%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.